We isolated the soluble forms of y-glutamyltransferase (EC 2.3.2.2; y-GT) from adult and fetal human liver and primary hepatoma and compared their properties. The Km value for L-y-glutamyl-p-nitroanilide and glycyiglycine, the K for anthglutin, and the pH optimum were identical for the enzyme from all three sources. Nor were significant differences observed among the three in their heat stability, inhibition by serine and borate, or ability to transfer the y-glutamyI moiety to various amino acids and dipeptides. Unlike membrane-bound y-GT, the soluble form from all three sources entered polyacrylamide gel and showed identical electrophoretic mobilities. Treatment with neuraminidase decreased the electrophoretic mobilities to a similar extent. The relative molecular mass of the enzyme from each of the three sources is about 84 000. Immunoinhibition and immunoprecipitation of y-GT from the three sources by antibody to fetal liver y-GT followed an identical pattern. 'y-GT from fetal liver and hepatoma differed significantly from that of adult liver in affinity for wheat-germ agglutinin and Ricinus communis agglutinin . In many of the properties studied, soluble y-GT resembles the papain-digested form of membrane-bound y-GT.
identical electrophoretic mobilities. Treatment with neuraminidase decreased the electrophoretic mobilities to a similar extent. The relative molecular mass of the enzyme from each of the three sources is about 84 000. Immunoinhibition and immunoprecipitation of y-GT from the three sources by antibody to fetal liver y-GT followed an identical pattern. 'y-GT from fetal liver and hepatoma dif- is increased in most hepatobiliary diseases, including malignancy of the liver (1) . ' In rat hepatoma and fetal liver the activity of 'y-GT reportedly is 100-fold that of adult liver (2). Reports from our laboratory (3) and others (4, 5) show that in human fetal liver and primary hepatoma, the activity of y-GT is three-to 13-fold that of adult liver. Sobiech and Szewczuk (6) described a variant form of y-GT found during development of human intestine. Kottgen et al. (7) reported the presence of a fetal form of y-GT in rat fetal liver and intestine but not in adult rat liver. Therefore, identification of such a variant form of 'y-GT associated with the development of human liver and primary hepatoma might serve as a useful diagnostic tool in the differential diagnosis of human primary hepatoma.
'y-GT exists in tissues as membrane-bound and "soluble" forms (8). The membrane-bound form can be solubilized by use of detergents such as Triton X-100 and deoxycholate or by treatment with papain (9).The membrane-bound 'y-GT has been purified and extensively characterized in various tissues (9) (10) (11) soluble y-GT. Earlier, we reported (3) that the membranebound y-GT in human adult liver, fetal liver, and hepatoma exhibits identical catalytic properties. Fujisawa et al. (12) reported a soluble form of this enzyme in human primary hepatoma and in sera of patients with hepatoma, which is immunologically identical to the solubleform of 'y-GT infetal liver but differs from the enzyme in normal serum. However, they failed to compare the soluble y-GT from adult liver with that of hepatoma. This prompted us to study and compare the properties of soluble y-GT in human adult liver, fetal liver, and hepatoma, to see whether there is any alteration in y-GT during oncofetal development of liver and, if so, whether this would be useful in the diagnosis of hepatoma. 
Materials and Methods

Reagents
Enzyme Assay and Unit
The enzyme was assayed by a modification of the method of Szasz (14) . We added 50 L of partly purified 'y-GT in Tris HCI buffer (50 mmol/L, pH 7.5) to 0. 
Procedures
Electrophoresis on polyacrylamide gel. Electrophoresis was carried out according to Davis (16) on polyacrylamide (70 g/L) slab gels. y-GT was located on the gels as described (17) , by using L-y-glutamyl-p-nitroanilide as substrate.
Neuraminidase treatment.
We incubated 1 mg of partly purified enzyme with 0.2 U of neuraminidase (EC 3.2.1.18) at 30#{176}C for 6 h in Tris HC1 buffer(50 mmol/L, pH 7.5;bufferA). Controls were subjected to the same treatment, but without neuraminidase. Immunological studies.
For immunoinhibition and immunoprecipitation studies we used rabbit antibody to membrane-bound y-GT that had been purified from human fetal liver. The y-GT was purified from human fetal liver by a procedure involving deoxycholate extraction of membranebound 'y-GT, precipitation with acetone and ammonium sulfate, chromatography on Phenyl-Sepharose CL-4B, digestion with papain (EC 3.4.22.2) and preparative electrophoresis on polyacrylamide gel. We mixed 300 zg of this purified y-GT with Freund's complete adjuvant and injected it subcutaneously into a six-month-old rabbit. On the 22nd day after the first injection we injected 150 zg of the enzyme subcutaneously, without adjuvant,as booster. On the seventh, eighth, and ninth day after this booster injection, the rabbit was bled, and IgG from the antiserum was purified (18) and used for inhibition and precipitation of y-GT. As a control, IgG was also purified from non-immune rabbit serum.
We mixed 4 mU of partly purified soluble y-GT with 0.1 mL of various concentrations of antiserum to fetal liver 'y-GT (IgG), incubated this at 4 #{176}C for 16 h, re-mixed, and took a 50-tL aliquot for inhibition studies. To the rest of the incubation mixture we added 20 1L of a 100 g/L formaldehydefixedStaphylococcus aureus (Cowan I)bacterial suspension (19) and centrifuged at 15 300 X g in a Beckman/Spinco Microfuge (Model 152A) for 5 mm to remove the enzyme-antibody complex (20) . The supernate was assayed for -y-GT activity. The enzyme-antibody complex was completely precipitated in all the experiments with the amount of bacterial suspension used.
We performed three types of control experiments. In the first and second, the antibody was replaced by non-immune IgG and buffer A, respectively.
In the third, the IgG and bacterial suspension were replaced by buffer A. Lectin-binding studies.
To a constant amount of enzyme, various concentrations of soluble lectins were added and incubated for 24 h at 4 #{176}C. After incubation, the mixture was centrifuged at 15 300 X g in the Microfuge for 10 mm. The supernate obtained was assayed fory-GT activity. We varied the ratio of protein to lectin from 1:0.25 to 1:5. The controls were subjected to the same treatment, but without lectins. For Co A, the incubation mixture was bufferA containing0.1mol of NaCl and 1 mmol each of CaC12 and MgCl2 per liter. For WGA and SBA the incubation mixture was buffer A containing 50 mmol of NaCl per liter, and for RCA-120 buffer A containing 0.1 mol of NaC1 per liter.
Dissociation of lectin-enzyme complex by specific sugars.
The enzyme was precipitated by incubating it with various lectins as described above. The concentration of lectin used was twice that of the enzyme protein for the Con A and RCA-120 experiments and fivefold greater for WGA. The precipitate obtained after centrifugation was suspended in 50 tL of various concentrations of sugars in buffer A and incubated for 2 h at 4 #{176}C (for WGA and RCA-120) or 25 #{176}C (for Con A). After incubation, we centrifuged the mixture as described before (15 300 X g) and assayed the supernate for y-GT activity.
The sugars used were a-methyl-D-mannoside (10 to 100 mmolfL), N-acetylglucosamine (1to 100 mmol/L), and lactose (1 to 100 mmol/L) in buffer A for dissociating the lectinenzyme complexes formed by Con A, WGA, and RCA-120, respectively. Normal adult liver, pooled fetal livers, and primary hepatoma of human-all of which had been stored at -20 #{176}C-were used for enzyme purification. The fetal livers were collected from human fetuses at 16 to 30 weeks of gestation. Unless otherwise stated, y-GT was isolated at4#{176}C.
The livers were homogenized for 3 mm at high speed in a Waring Blendor with 10 volumes of a solution containing, per liter, 80 mmol of MgCl2 and 0.75 mmol of NaOH. This homogenate was then stirred for 2 h and centrifuged (40 000 X g, 30 mm). The supernate was taken as the "soluble" fraction (12) . To the supernate we added solid (NH4)2SO4 (to a final concentration of 250 g/L), stirred for 30 mm, centrifuged, and discarded the pellet. The (NH4)2S04 concentration in the supernate was further increased to 800 g/L, and itwas stirred for 30 mm, then centrifuged again (12 000 X g, 30 mm). The resulting pellet was dissolved in Tris HC1 buffer (50 mmol/L, pH 7.0) and dialyzed against the same buffer. The dialyzate was loaded on a DE-52 column equilibrated with the buffer used for dialysis and the unbound proteins were washed out with more of the same buffer. The bound enzyme was eluted as a single peak with dialysis buffer containing 0.2 mol of NaCI per liter. The active fractions were pooled, dialyzed against buffer A, and loaded on a Phenyl-Sepharose CL-4B column equilibrated with buffer A. The unbound y-GT that eluted was collected and concentrated by use of Aquacide II (Calbiochem, San Diego, CA 92112). The concentrated enzyme was dialyzed against buffer A and used for all studies described unless otherwise stated.
Results
Enzyme Characterization
Purification.
Storage of tissue at -20 #{176}C did not result in any significant loss of y-GT activity. The specific activities of the y-GT in homogenates of adult liver, fetal liver, and primary hepatoma were 0.015, 0.096, and 0.183 kU/g, respectively. The proportions of y-GT recovered in the 40 000
X g supernates of homogenates of adult or fetal liver and hepatoma were 7, 5, and 7%, respectively. Because of the small amount of enzyme in the supernate we were only able toply purify it. The enzyme obtained from adult liver, fetal liver, and hepatoma in the final step of purification showed a specific activity of 0.033, 0.07, and 0.146 kU/g with 26, 32, and 39% recoveries, respectively, from the 40 000 X g supernate.
Kinetic constants and catalytic properties.
As shown in Table 1 , the pH optimum for y-GT from adult liver, fetal liver, or hepatoma was similar for transpeptidation and autotransfer reactions. The enzymes from all the three sources exhibited a similar Km value for L-'y-glutamyl-p-nitroanilide and glycylglycine and K for anthglutmn. Amino acids and dipeptides as ','-glutamyl acceptors. Table 2 shows the activityof y-GT when glycylglycinewas replaced by various amino acids and dipeptides. Of the amino acids we tested, cystine and glutamine were good acceptors. Other amino acids (not shown in the Table) decreased the mobility of y-GT from all the three sources to had no influence on enzyme activities. We observed no difference in the behavior of the enzyme from each of the three sources towards metal ions. EDTA at 5 mmolfL did not influence enzyme activity. Effect of serine and borate. Figure 1 milustrates the inhmbition pattern of 'y-GT activity by various concentrations of serine plus borate. Serine and borate, each at 15 mmol/L in the reaction mixture, completely inhibited the enzyme activity from all three sources. Borate (15 mmol/L) alone had no influence on the enzyme activity, whereas serine alone (15 mmolfL) inhibited y-GT activity by about 20%. Effect of urea, sodium dodecyl sulfate, iodoacetamide, and p-hydroxymercuribenzoate.
mmol/L) in the assay mixture did not affect the enzyme activity from any of the three sources. Activity of the enzyme from any of the three sources was inhibited by 30% by iodoacetamide (10 mmol/L) and 100% by sodium dodecyl sulfate (5 g/L) in the assay mixture.
Thermal stability.
Heat-inactmvatmon studies showed that the enzyme from all three sources was inactivated at 58 #{176}C within 10 mm and that the addition of reduced glutathione (20 mmol/L) protected 1-GT against heat inactivation for up to 50 mm. Figure 2 shows results of the molecular mass determination of y-GT by gel filtration. The estimated relative molecular mass of 1-GT from all the three sources was identical, about 84 000. The relative molecular mass of the papain-digested form of membrane-bound y-GT from adult liver was 82 000.
Molecular mass.
Electrophoretic mobility.
The partly purified y-GT from 0 15.0 X 10-6 14.0 X 10-6
Tris HCI buffers in the pH range 7.0-9.0 were used to determine pH optIma. For autotransfer reactions glycylglycine was omittedfrom theusual reaction mixtixe.
The Km values were determined by thedole-reciprocai method. The K1for anthglutin was determined by Dixon plots of results with 1.2, and 4 mmnol/L concentrations of L-7-glutamyl-p-nltroaniiide.
>. before papain digestion, after papain digestion,and treated with neuraminidase after papain digestion, respectively. Other experimental details are given in the text a similar extent, without affecting enzyme activity. In contrast to the soluble form, the undigested membrane-bound form remained in the origin of the gel.
Immunoinhibition
and immuno precipitation studies. Figure 4 shows the inhibition and precipitation of 'y-GT by antibody to membrane-bound 'y-GT purified from human fetal liver. The soluble form of y-GT from all the three sources was completely precmpitable by anti-fetal lmver y-GT. The inhibition and precipitation curves for adult liver, fetal liver, and hepatoma y-GT followed an mdentical pattern and were superimposable.
Figure 4 also shows that y-GT activity was not completely inhibited by antiserum to fetal liver y-GT. In other words, the enzyme-antibody complex of adult liver, fetal liver, and hepatoma each retained 50% of the free enzyme activity.
Lectin-Binding Studies
Interaction of y-GT with soluble lectins. As Table 3 shows, 80, 73, and 68% of the adult liver, fetal liver, and hepatoma enzymes, respectively, were precipitated by Con A when the concentration of lectin was twice that of enzyme protemn. Increasing the ratio of lectin to protein to 10:1 did not produce any further precipitation.
WGA precipitated 100, 80,and 71% of the adult liver, fetal liver, and hepatoma y-GT, respectively, when the ratio of -lectin to protein was 5:1. This difference in precipitation be-
?.
tween fetal and hepatoma -y-GT and that of adult -y-GT was more pronounced (Table 3) when the ratio of lectin to enzyme protein was reduced to 1:1. A significant difference between adult and fetal liver y-GT was observed by RCA-120 precipitation when the ratio of lectin to enzyme protein concentration was 1:2,but thisdifference diminished on increasing the lectin concentration (Table 3) .
SBA did not precipitate 'y-GT from any of the three sources. did not reveal any differences among the three enzyme preparations. Figure 5A shows the dissociation of WGA-enzyme complex by N-acetylglucosamine.
The pattern for fetal liver and hepatoma enzyme differed from that of adult liver enzyme. At an N-acetylglucosamine concentration of 1 mmol/L, 17% of the adult enzyme, 98% of the fetal enzyme, and 81% of the hepatoma enzyme were released from the complex; at 100 mmolfL, the dissociation of adult liver enzyme from the complex was complete.
The pattern of dissociation of RCA-120-enzyme complex by lactoseisshown in Figure 5B . The pattern for the adultliver enzyme differed from that for fetal liver and hepatoma for lactose concentrations as high as 5 mmol/L, but not when the lactose was increased to 10 mmol/L.
Discussion
The partly purified soluble y-GT has a molecular mass similar to that of hepatoma-specific soluble form of y-GT described by Fujisawa et al. (12) . Szewczuk (8) , who first demonstrated the soluble form of 'y-GT invarious tissues, also found its relative molecular mass to be 80 000 to 90 000. We have observed that the papain-digested membrane-bound form of 'y-GT does not bind to Phenyl-Sepharose CL-4B and had an electrophoretic mobility and molecular mass similar to that of soluble 'y-GT. Moreover, the electrophoretic mobility of the soluble and papain-digested membrane-bound 'y-GT is decreased to the same extent by neuraminidase treatment. Thus the soluble enzyme may originate from the membrane-bound y-GT by a mechanism similar to that of papain digestion.
We find the soluble form of y-GT from adult liver, fetal liver, and hepatoma to be identical in its kinetic constants and catalytic properties, and similar to those reported for membrane-bound 'y-GT (3). The soluble enzyme from all three sources also shows similarities in heat stability, molecular mass, and electrophoretic mobility. Reportedly (22), 1-GT derived from various organs from the same species differs in electrophoretic mobility because of differences in sialic acid content. Kottgen et al. (7) demonstrated in rats that the 'y-GT in fetal liver is more sialylated than that in adult liver. However, our results suggest that y-GT from human adult liver, fetal liver, and hepatoma are sialylated to an equal extent.
Our immunoinhibition and immunoprecipitation studies demonstrated that the enzyme from any of the three sources possesses identical antigenic determinants, and that the soluble and membrane-bound 'y-GT have common antigenic determinants, the soluble y-GT being completely precipitated by the antibody to membrane-bound 'y-GT. This observation does not agree with that of Fujisawa et al. (12) , who found that the membrane-bound and soluble y-GT of hepatoma differed immunologically.
Partlypurifiedmembrane-bound 'y-GT from human adult liver, fetal liver, and hepatoma binds to Con A-Sepharose 4B (3). Shaw et al. (23) and Huseby (24) reported that membrane-bound "y-GT in adult human liver can be precipitated by soluble Con A. In accordance with these observations, we alsofound that the solubleform of y-GT from adult human liver can be precipitated by soluble Con A. As observed for membrane-bound enzyme (3), the soluble form of human adult and fetal liver 'y-GT were not differentiated by Con A. Kottgen et al. (7), using Con A-Sepharose, found a sialic acid-rich (fetal form) and a sialic acid-poor (adult form) of 'y-GT in fetal and adult rat liver, respectively.
They also showed that the fetal form of 'y-GT binds to Con A-Sepharose after treatment with neuraminidase. These contradictory observations may result from differences in the degree of sialylation of 'y-GT in rat and human, or from differences in the experimental conditions used. However, Ellison et al. (25) failed to differentiate fetal and adult forms of 7-GT from rat liver when they used Con A-Sepharose under the experimental conditions described by Kottgen et al. (7).
Precipitation
of y-GT with WGA and RCA-120 and the dissociation of the enzyme-lectin complex with specific sugars showed significant differences in y-GT from the three sources.
The y-GT from fetal liver and hepatoma showed a weaker affinity for WGA than did 'y-GT from adult liver, a higher concentration of N-acetylglucosamine being needed to dissociate the WGA-enzyme complex formed by the adult enzyme. RCA-120 precipitation studies showed that the fetal enzyme can be precipitated with a lower concentration of lectin than the adult liver enzyme. Differences were also observed between fetal and adult enzyme in the dissociation of RCA-120-enzyme complex at lower concentrations of lactose.
These results suggest that the carbohydrate composition of the fetal liver enzyme may differ from that of adult liver enzyme, and that the carbohydrate moiety of hepatoma y-GT may be very similar to (if not the same as) that of fetal enzyme. 
